How Should Companies Budget for PCT International and National Phases in 2026?

A reliable PCT budget should cover two different events: the international phase, which creates a common application and includes an international search, and the national or regional phase, where designated offices examine the same patent application under their own law. A PCT filing does not itself produce a “world patent,” and its international-phase fees represent only part of the total cost. The planning date for this answer is 27 September 2026, but official fee schedules, exchange rates, and office deadlines should be checked again immediately before filing and entry.

What Does a PCT National-Phase Budget Actually Cover?

Also worth reading: Madrid System fee calculator 2026: what are the current WIPO international trademark filing fees and how do I budget them? · How Much Do International Patent Filing Costs in 2026? · What Are Realistic Patent Prosecution Cost Benchmarks for U.S. and International Filings in 2026?

A PCT national-phase budget normally has four cost layers. The first is the international filing package: the PCT application fee, priority claims, description, claims, drawings, abstract, and the transmittal paperwork. The second is the international-search cost, including the competent International Searching Authority’s fee. The third includes international-phase expenses such as page surcharges, the Chapter II demand fee if applicable, and selected-appendix requests. The fourth is the much larger set of jurisdiction-specific charges payable after national-phase entry, including translation, national fees, attorney fees, examination fees, grant or publication fees, and annuity payments.

Those categories should be modeled separately because they occur at different times and have different currencies. For a company with inventions filed in multiple countries, a spreadsheet might show a PCT filing phase in 2026, a demand or selection decision in 2027, and national-phase entries in 2028 or 2029. A 2026 spending cap alone is therefore misleading: substantial costs may fall outside the fiscal year in which the PCT application is filed. Patent counsel should also distinguish cash flow, accrual accounting, and official-budget ownership so that a central R&D budget is not unexpectedly charged for local prosecution expenses.

## How Is the International-Phase Budget Built?

The international phase begins before the publication date fixed by the PCT. For an application claiming a priority date, the usual PCT filing deadline is 12 months after that priority date, not necessarily 12 months after an internal disclosure. Chapter I generally runs for 18 months from the priority date, and publication normally occurs at the end of that period. Chapter II is triggered by a demand in a second designated State, generally at or before 22 months from the priority date; a demand may also be made at 22 months for an earlier international search report within the relevant conditions. Chapter II is optional, but entering it can affect national-phase timing and cost.

The most visible international-phase figures are official fees rather than professional fees. As a planning reference, WIPO’s international application fee has recently been around CHF 1,330 for a 30-sheet application, with a surcharge commonly assessed for sheets beyond 30; the precise amount can be indexed or revised. An ISA search fee is additional, and the competent authority must be selected before filing if the applicant wants to rely on its search report. The PCT Applicant’s Guide and WIPO’s current fee calculator should control, because authorities may charge in different currencies and some offices distinguish applicants with fewer than 30 sheets, small-entity status, or other cases.

A defensible model should include internal labor even if procurement treats it as sunk cost. Invention disclosure processing, inventor interviews, claim drafting, drawings, review, translation coordination, and approval meetings can exceed official charges. On the other hand, it would be poor budgeting to assume that every PCT filing must proceed to a demand in every region. The preferred market list, anticipated product launch, remaining commercial life, and probability of grant should decide which jurisdictions deserve full prosecution expenditure.

Why Do National-Phase Fees Vary So Much?

National-phase cost is determined by the receiving office, not by one universal PCT tariff. Under PCT Article 22, as discussed in the EPO’s national-phase materials, the designated office generally permits entry on a 30-month term; Article 39 can provide a 31-month term in certain circumstances, including delayed publication under PCT Article 39(1). WIPO’s PCT Applicant’s Guide and each receiving office’s current rules determine whether restoration is available. The budget should therefore use “30 or 31 months after the priority date” as a planning statement, while recording the actual deadline for each office.

European patent applications provide one useful comparison with country filings. Entry in the European patent system generally involves a filing fee plus a European translation, followed by examination and grant fees under the European Patent Convention framework. A direct national filing in Germany, France, or the United Kingdom can have a different official-fee structure and can produce a national right sooner. A European application may consolidate proceedings across the relevant states, but coverage, translation, renewal fees, and post-grant choices still depend on the intended commercial footprint. By contrast, entering India, Japan, China, and the United States creates four office-specific workstreams rather than one globally harmonized examination.

Translation can become a major variable. WIPO or a receiving office may require a translation into an accepted language, and a certified or verified translation may be required. A five-page legal text translated by one provider does not scale predictably to a complex 80-page specification. Budgets should use actual word counts, likely office fees, amendments, and a contingency rather than assume that machine translation has the same quality and cost as a human patent translation. The EPO warns, in its national-phase guidance, that applicants remain responsible for the accuracy and completeness of translated text; formal filing does not remove that responsibility.

What Is a Sensible Planning Range for 2026?

There is no honest single global price because a simple PCT filing with no demand and a 20-country national strategy are different projects. A practical planning reserve for official international-phase fees alone is often about CHF 2,000 to CHF 3,000 for a typical filing, search, and limited extra pages, although the actual ISA fee, extra-page charges, demand decision, and currency movement can move the total above or below that range. If European search is selected, the search component may itself be roughly EUR 1,800 at recent published levels, while the international filing fee remains in Swiss francs. These figures are budgeting assumptions rather than quotations for 2026.

A modest national strategy involving two or three carefully selected jurisdictions might be planned around several thousand to tens of thousands of U.S. dollars once drafting, translations, searches, local counsel, and prosecution are included. A high-value portfolio entering Europe, the United States, China, Japan, and India can reach five figures per family more readily, especially when complex amendments and office actions are required. Maintenance is additional: a granted patent can require annual or quarterly fees for decades, and many offices charge renewals from the third year, with the amount and escalation varying by jurisdiction. The PCT system therefore does not remove the long tail cost of patent ownership.

## What Practical Process Should a Product or Legal Team Follow?

Start with commercial prioritization rather than geography. A company should identify where products will be made, sold, hosted, imported, or protected, and should consider service restrictions and third-party licensing. Patentability and market value should then be scored separately, because a commercially attractive market can be a poor first filing jurisdiction for cost or enforcement reasons. A disciplined review may select two “must-have” markets and two “later-entry” markets, reducing expenditure when the business changes.

Next, establish dates at both the application level and portfolio level. Record the earliest priority date, 12-month PCT filing date, 18-month publication date, any 22-month demand date, and the expected 30- or 31-month national-entry deadline. Use an independent docket-control system rather than relying on the law firm’s general email reminders. Where internal budgets permit, create three scenarios: a minimum viable country set, the expected commercial set, and an opportunistic set for negotiations or licensing. Each scenario should state what is deferred and what deadline would force a late filing.

The cost sheet should then distinguish official fees, external counsel, internal labor, translation, annuity exposure, and contingency. Currency risk deserves its own line: an estimate denominated only in dollars can become inaccurate when the relevant charges are payable in Swiss francs or euros. A 5% to 10% contingency is often reasonable for uncertainty in fee updates and page counts, but it should not be used to conceal a missing scope. Before approval, compare the expected cost with the patent’s expected useful life; a product launching in less than 18 months may need a different filing and prosecution sequence from one launching five years later.

Which Alternatives to a PCT Filing Should Be Compared?

Direct national or regional filing is the principal alternative. A first filing in one or two countries can avoid international-phase machinery and may provide speed in a strategically important market, but it is not a substitute for preserving options in every desired country by the applicable priority deadline. Madrid and Hague systems are also relevant where trade marks or designs are involved, but they do not replace the PCT for patent applications. A company that selects a national-first strategy should compare legal coverage, deadline control, search authority, translation needs, and total expected prosecution cost rather than focusing on the initial filing fee.

A regional application can be cheaper than several direct national filings when the commercial target is a recognized regional market. However, regional systems are not interchangeable with the PCT. The European patent route, for example, is a national-phase destination, not a substitute for international filing under the PCT. Deferred PCT filing is another alternative: an applicant may first file nationally and enter the PCT route at 12 months in accordance with the applicable rules, but the later path may be administratively more complex and the first search may not match the later international strategy.

The choice should be made at the portfolio level. Filing every invention internationally because one flagship product merits broad protection can waste budget, while filing only in the country where engineering is located can ignore the market where infringement or licensing is most likely. The better method is a gate process based on expected exclusivity, product revenue, competitor activity, claim scope, market-access issues, and the cost of later enforcement. The PCT is most useful as a coordinated option-preservation tool, not as an automatic instruction to enter everywhere.

Common Budgeting Mistakes and When to Act

The most frequent mistake is treating the PCT filing fee as the total price. That understates translation, national filing, examination, local counsel, and maintenance costs by potentially an order of magnitude. A second error is waiting for the international search report before deciding whether to fund a demand or entry. The demand decision can have a deadline around 22 months, while national entry may be due at 30 or 31 months from priority, so waiting for a complete commercial analysis at 29 months is too late. A third error is using a generic 12-month deadline from the PCT filing date rather than calculating from the earliest priority date.

Other problems include ignoring the cost of long specifications, assuming small-entity reductions will apply, or postponing annuity planning. Applicants should also confirm whether a national-phase deadline is absolute, extendable, or restorable, and whether a missed translation or fee can be corrected. Failure to enter a jurisdiction is not automatically harmless: it may permanently prevent patent rights there, although domestic and regional laws can sometimes permit restoration within a strict period. Estimates should record whether a deadline is statutory, official practice, or merely an internal target.

The planning trigger is the first priority date, not the date a committee happens to meet. A company should begin its market, claim, and budget review at disclosure; lock the filing and cost assumptions before the 12-month deadline; decide whether a demand is needed before 22 months; and freeze national decisions early enough for translations, translations review, and local filings. For a 1 June 2024 priority date, for example, the ordinary PCT filing point would fall around 1 June 2026, the Chapter II decision point around 1 April 2027, and a typical national-entry point around 1 December or 1 January 2028, subject to the actual rules and office. Those dates illustrate why a 2026 budget must reserve money for later years.

A Defensible Budgeting Model for IP Teams and SaaS Registry Workflows

For counsel and product teams, PCT budgeting works best when the legal system and the internal approval system are connected. A registry or docketing workflow can link an invention to its priority dates, selected markets, official-fee estimates, translation status, annuity dates, and approval owner. The workflow should not imply that a registry filing itself changes legal deadlines. It should make deadlines, assumptions, currencies, and document versions visible so that a product team can forecast spend and legal counsel can update the actual budget without losing the audit trail.

A strong model uses a base case plus named scenarios. The base case might cover a two-market national strategy, one search, no Chapter II demand, and a defined translation budget. The growth case might add four markets, European regional coverage, and an annuity reserve. The downside case should show what happens if a key claim is amended, an office action requires a second translation, or a currency rate changes. Every scenario should identify the decision date, the amount payable, the recipient, the currency, the responsible owner, and the consequence of nonpayment.

The governing principle is proportionality. Spend where exclusivity, licensing, market access, or defensive value justifies it; defer low-probability markets; and preserve the dates that keep options open. This is especially important for smaller companies, where a broad PCT budget can crowd out product development, while a narrow budget can miss a commercially important market. A neutral registry SaaS platform can improve visibility and cost control, but it should not replace a qualified patent attorney’s advice on jurisdiction selection, legal deadlines, translations, or the merits of protection.